Notices. Notification; petition for rulemaking
374 words·~2 min read·
/register/2017/09/25/2017-20385A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4910-13-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 573 [Docket No. FDA-2017-F-5528] Idemitsu Kosan, Cp. Ltd.; Filing of Food Additive Petition (Animal Use) AGENCY: Food and Drug Administration, HHS. ACTION: Notification; petition for rulemaking. SUMMARY: The Food and Drug Administration (FDA or we) is announcing that Idemitsu Kosan, Cp. Ltd. has filed a petition proposing that the food additive regulations be amended to provide for the safe use of silicon dioxide as a carrier for flavors for use in animal feed.
DATES: The food additive petition was filed on August 7, 2017. ADDRESSES: For access to the docket, go to *https://www.regulations.gov* and insert the docket number, found in brackets in the heading of this document, into the “Search” box and follow the prompts; and/or go to the Dockets Management Staff, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. FOR FURTHER INFORMATION CONTACT: Chelsea Trull, Center for Veterinary Medicine, Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-402-6729, *chelsea.trull@fda.hhs.gov.* SUPPLEMENTARY INFORMATION:
Under the Federal Food, Drug, and Cosmetic Act (section 409(b)(5) (21 U.S.C. 348(b)(5))), notice is given that a food additive petition (FAP 2304) has been filed by Idemitsu Kosan, Cp. Ltd., Agri-Bio Business Dept., 1-1 Marunouchi 3-Chome, Chiyoda-Ku, Tokyo 1000-8321, Japan. The petition proposes to amend Title 21 of the Code of Federal Regulations
(CFR)in part 573 (21 CFR part 573) *Food Additives Permitted in Feed and Drinking Water of Animals* to provide for the safe use of silicon dioxide (21 CFR 573.940) as a carrier for flavors for use in animal feed. The petitioner has claimed that this action is categorically excluded under 21 CFR 25.32(r) because it is of a type that does not individually or cumulatively have a significant effect on the human environment. In addition, the petitioner has stated that, to their knowledge, no extraordinary circumstances exist. If FDA determines a categorical exclusion applies, neither an environmental assessment nor an environmental impact statement is required. If FDA determines a categorical exclusion does not apply, we will request an environmental assessment and make it available for public inspection. Dated: September 19, 2017. Anna K. Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis. [FR Doc. 2017-20385 Filed 9-22-17; 8:45 am]
Connectionstraces to 3
Traces to 3 documents
1 reference not yet in our index
- 21 CFR 573
Citation graph
cites case law
Cites 4Cited by 0 across 0 sources